Richard.DeWald@f70.n382.z1.fidonet.org (Richard DeWald) (10/15/90)
In an article of <10 Oct 90 22:29:34 GMT>, cwt@isl.Stanford.EDU (Chien-Wen
Tseng) writes:
CT>Develop a syringe with a retractable protection for the needle.
It has been done, they cost 3X as much as a regular syringe.
The risk of seroconversion (becoming HIV+) after a needle stick is 1:100.
Richard DeWald, BSN Student
Univ. of TX - Austin.
--
Uucp: ...{gatech,ames,rutgers}!ncar!asuvax!stjhmc!382!70!Richard.DeWald
Internet: Richard.DeWald@f70.n382.z1.fidonet.orgDave.Wilson@p0.f433.n104.z1.fidonet.org (Dave Wilson) (10/15/90)
* Replying to a message originally to Chien-wen Tseng
RD>In an article of <10 Oct 90 22:29:34 GMT>,
RD>cwt@isl.Stanford.EDU (Chien-Wen Tseng) writes:
RD> CT>Develop a syringe with a retractable protection for the needle.
RD>It has been done, they cost 3X as much as a regular syringe.
RD>The risk of seroconversion (becoming HIV+) after a needle
RD>stick is 1:100.
RD>
RD>Richard DeWald, BSN Student
RD>Univ. of TX - Austin.
Hi Richard: the 1:100 risk involves only needles that have been
used on HIV+ patients. Hate to nitpick, but lack of precision is
how rumors and bogus statistics get started.
--
Uucp: ...{gatech,ames,rutgers}!ncar!asuvax!stjhmc!104!433.0!Dave.Wilson
Internet: Dave.Wilson@p0.f433.n104.z1.fidonet.org